Canton Strategic Holdings, Inc. (CNTN)
NASDAQ: CNTN · Real-Time Price · USD
4.070
-0.125 (-2.98%)
At close: Mar 13, 2026, 4:00 PM EDT
4.120
+0.050 (1.22%)
After-hours: Mar 13, 2026, 6:41 PM EDT
Canton Strategic Holdings Market Cap
Canton Strategic Holdings has a market cap or net worth of $209.68 million as of March 13, 2026. Its market cap has increased by 7,080.92% in one year.
Market Cap
209.68M
Enterprise Value
204.84M
1-Year Change
7,080.92%
Ranking
Category
Stock Price
$4.07
Market Cap Chart
Since January 12, 2022, Canton Strategic Holdings's market cap has increased from $32.56M to $209.68M, an increase of 543.94%. That is a compound annual growth rate of 56.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 216.12M | 95.71% |
| Dec 31, 2025 | 110.43M | 2,713.07% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -86.20% |
| Jan 12, 2022 | 32.56M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sol-Gel Technologies | 254.06M |
| Alector | 253.83M |
| Nuvectis Pharma | 245.05M |
| SAB Biotherapeutics | 232.34M |
| Protalix BioTherapeutics | 230.81M |
| Humacyte | 228.70M |
| Achieve Life Sciences | 226.24M |
| Keros Therapeutics | 224.78M |